More personalized breast cancer prevention with BREVAGen

BREVAGen™ is an exciting new, clinically validated predictive test for breast cancer.  It is a test for the sporadic (not familial like BRCA 1 & 2) breast cancers, the other 80% or more common ones.  Most of these cancers are estrogen-positive cancers (75%).  The test results allow us to develop a personalized screening and prevention plan for each individual.


The test combines genetic markers (7 SNP's) from an inner cheek swab with clinical information about estrogen exposure, family history and breast biopsy history to give a lifetime risk and a five year risk.  It is these two numbers that allow us to make an individualized action plan.  In studies, the combination of clinical features plus the genetic information has proven to be superior than either alone.


Who should ask for one?


BREVAGen currently approved for women:

• 35 years or older
• Caucasian women (other ethnicities are being investigated)
• May have a higher than usual breast cancer risk
• Negative BRCA 1 or 2 test
• Have had a breast biopsy
• Are concerned about breast cancer risk

Call or come by to find out if this is the right test for you....and bring a friend.   www.owenwinsettmd.com. 

Together we can prevent 75,000 breast cancer cases each year!